These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8425544)

  • 1. Structural characterization of a biologically active human lipocortin 1 expressed in Escherichia coli.
    Arcone R; Arpaia G; Ruoppolo M; Malorni A; Pucci P; Marino G; Ialenti A; Di Rosa M; Ciliberto G
    Eur J Biochem; 1993 Jan; 211(1-2):347-55. PubMed ID: 8425544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector.
    Arcone R; Pucci P; Zappacosta F; Fontaine V; Malorni A; Marino G; Ciliberto G
    Eur J Biochem; 1991 Jun; 198(3):541-7. PubMed ID: 2050135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity.
    Wallner BP; Mattaliano RJ; Hession C; Cate RL; Tizard R; Sinclair LK; Foeller C; Chow EP; Browing JL; Ramachandran KL
    Nature; 1986 Mar 6-12; 320(6057):77-81. PubMed ID: 2936963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of proteolytic fragments of lipocortin I that inhibit phospholipase A2.
    Huang KS; McGray P; Mattaliano RJ; Burne C; Chow EP; Sinclair LK; Pepinsky RB
    J Biol Chem; 1987 Jun; 262(16):7639-45. PubMed ID: 2953722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1.
    Cirino G; Cicala C; Sorrentino L; Ciliberto G; Arpaia G; Perretti M; Flower RJ
    Br J Pharmacol; 1993 Mar; 108(3):573-4. PubMed ID: 8467352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric analysis of human soluble catechol O-methyltransferase expressed in Escherichia coli. Identification of a product of ribosomal frameshifting and of reactive cysteines involved in S-adenosyl-L-methionine binding.
    Vilbois F; Caspers P; da Prada M; Lang G; Karrer C; Lahm HW; Cesura AM
    Eur J Biochem; 1994 Jun; 222(2):377-86. PubMed ID: 8020475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel anti-inflammatory peptide from human lipocortin 5.
    Perretti M; Becherucci C; Mugridge KG; Solito E; Silvestri S; Parente L
    Br J Pharmacol; 1991 Jun; 103(2):1327-32. PubMed ID: 1832064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site.
    Kim SW; Rhee HJ; Ko J; Kim YJ; Kim HG; Yang JM; Choi EC; Na DS
    J Biol Chem; 2001 May; 276(19):15712-9. PubMed ID: 11278580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of phospholipase A2 inhibitory proteins in human mononuclear cells.
    Coméra C; Rothhut B; Russo-Marie F
    Eur J Biochem; 1990 Feb; 188(1):139-46. PubMed ID: 2138536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipocortin 1 and the control of cPLA2 activity in A549 cells. Glucocorticoids block EGF stimulation of cPLA2 phosphorylation.
    Croxtall JD; Choudhury Q; Newman S; Flower RJ
    Biochem Pharmacol; 1996 Jul; 52(2):351-6. PubMed ID: 8694860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test.
    Cirino G; Peers SH; Flower RJ; Browning JL; Pepinsky RB
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3428-32. PubMed ID: 2470103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies specific to a Ca2(+)-bound form of lipocortin I distinguish its Ca2(+)-dependent phospholipid-binding ability from its ability to inhibit phospholipase A2.
    Hayashi H; Owada MK; Sonobe S; Domae K; Yamanouchi T; Kakunaga T; Kitajima Y; Yaoita H
    Biochem J; 1990 Aug; 269(3):709-15. PubMed ID: 2143895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric and Edman sequencing of lipocortin I isolated by two-dimensional SDS/PAGE of human melanoma lysates.
    Hall SC; Smith DM; Masiarz FR; Soo VW; Tran HM; Epstein LB; Burlingame AL
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1927-31. PubMed ID: 8446611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of natural lipocortin I. A potent mediator for macrophage-mediated immunosuppression in tumor-bearing mice.
    Sakata T; Iwagami S; Tsuruta Y; Suzuki S; Suzuki R
    J Immunol; 1993 Nov; 151(9):4964-72. PubMed ID: 8409450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family.
    Tait JF; Sakata M; McMullen BA; Miao CH; Funakoshi T; Hendrickson LE; Fujikawa K
    Biochemistry; 1988 Aug; 27(17):6268-76. PubMed ID: 2975506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to lipocortin-1 as probes for biological function.
    Pepinsky RB; Sinclair LK; Dougas I; Liang CM; Lawton P; Browning JL
    FEBS Lett; 1990 Feb; 261(2):247-52. PubMed ID: 1690147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant lipocortin 1 (annexin 1) has anticoagulant activity on human plasma in vitro.
    Cirino G; Cicala C
    J Lipid Mediat; 1993 Oct; 8(2):81-6. PubMed ID: 8268457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric characterization of the human androgen receptor ligand-binding domain expressed in Escherichia coli.
    Zhu Z; Becklin RR; Desiderio DM; Dalton JT
    Biochemistry; 2001 Sep; 40(36):10756-63. PubMed ID: 11535050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.
    Märki F; Pfeilschifter J; Rink H; Wiesenberg I
    FEBS Lett; 1990 May; 264(2):171-5. PubMed ID: 2141575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase.
    Moreno JJ
    Int Immunopharmacol; 2006 Feb; 6(2):300-3. PubMed ID: 16399636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.